| Market Cap | ₹35Cr |
| ROE | 2.04% |
| P/E Ratio(TTM) | 76.26 |
| EPS(TTM) | 0.23 |
| P/B Ratio | 1.54 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.28 |
| Book Value | 11.36 |
| Debt to Equity | 0.20 |
| Face Value | 10 |
| Parent Organisation | Veerhealth Care Limited |
| Managing Director | Mr. Bhavin Shah |
| BSE Symbol | 511523 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 58.99 | ||
| Ajanta Pharma | NA (0.00%) | 32.29 | ||
| Gland Pharma | NA (0.00%) | 36.94 | ||
| Eris Lifesciences | NA (0.00%) | 48.78 |